Featured series 
Tag: Bradley T. Hyman
-
Health
Lighting up Parkinson’s disease research
Most people do not think of jellyfish at the mention of Parkinson’s disease research. But, at the MassGeneral Institute for Neurodegenerative Disease (MIND), researchers Pamela McLean and Bradley Hyman are using the same fluorescent protein that causes the green glow of jellyfish for their experiments testing potential drugs for the treatment of Parkinson’s disease (PD).…
-
Health
Compound traces brain plaques in real time
Alzheimer’s disease is notoriously difficult to diagnose. Though sophisticated functional and cognitive tests can help, they often fail to distinguish between Alzheimer’s and other non-amyloid-based dementias, particularly frontotemporal dementia. The ability to measure plaques in vivo would not only provide clinicians with an immediate and reliable diagnosis, but over time would allow them to gauge…
-
Health
Majority of Alzheimer’s plaques cleared from brains of living mice
Harvard Medical School researchers, working with scientists at Elan Pharmaceuticals, cleared 70 percent of Alzheimer’s plaques from the brains of mice by applying anti-plaque antibodies directly to the mouse brains through tiny holes in their skulls. A year and a half before, Elan scientists showed that they could prevent plaque formation in the Alzheimer’s-prone mice…